Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective.
The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.

Currenty, no new investments are being sought.

Text size

Helping to build companies in the life science

adding value to the portfolio companies
a tailored approach
access to expertise

GLSV uses its exclusive focus on the life sciences and the experience of its team and advisors to assist in building companies.Through its international orientation and long-term commitment, the partnership has been able to develop a global outlook that brings major benefits to its portfolio companies. At the same time, the partnership has strategically channelled its resources into developing the infrastructure necessary to support its investees. A presence in several European locations enables GLSV to work closely with enterprises by providing tailored assistance as and when it is needed.